Ventana Announces FDA Approval Of Antibody To Assess Whether Breast Cancer Patients Should Be Treated With Herceptin
Ventana Medical Systems announced Wednesday it has received FDA approval for an antibody to aid in assessing whether breast cancer patients should be treated with [click link for full article]